Tumor necrosis factor-α does not modulate ischemia/reperfusion injury in naïve myocardium but is essential for the development of late preconditioning

The role of tumor necrosis factor (TNF)-α in myocardial ischemia/reperfusion injury remains controversial. We used homozygous TNF-α null mice (TNF-α–/–) to determine whether TNF-α modulates myocardial ischemia/reperfusion injury. Mice were subjected to a 30-min coronary occlusion followed by 24 h of reperfusion. When wild-type mice were preconditioned with six cycles of 4-min coronary occlusion/4-min reperfusion 24 h before the 30-min occlusion, infarct size was reduced from 58.6 ± 1.9% of the risk region to 19.3 ± 3.6%, indicating a late preconditioning (PC) effect. In non-preconditioned TNF-α–/– mice, infarct size was similar to that observed in wild-type mice (55.5 ± 3.7%). However, in TNF-α–/– mice preconditioned with six occlusion/reperfusion cycles 24 h earlier, infarct size was not reduced (55.2 ± 5.7%), indicating that the late PC protection against infarction was completely abolished. While minimal TNF-α immunoreactivity was detected in sham-operated hearts, extensive TNF-α expression was noted in the cytoplasm of cardiomyocytes in the ischemic/reperfused region 30 min after the PC ischemia. At 30 min after PC, wild-type mice exhibited increased DNA-binding activity of nuclear factor-kappa B (NF-κB) and activator protein-1 (AP-1) and nuclear translocation of p65, c-Jun and c-Fos; all of these changes were absent in TNF-α–/– mice. These data demonstrate that TNF-α does not modulate infarct size in the naïve (non-preconditioned) state but is essential for the development of the late phase of ischemic PC, possibly via the activation of NF-κB and AP-1 transcription factors.